ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction

ClinicalTrials.gov ID: NCT02927912

Public ClinicalTrials.gov record NCT02927912. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multi-institution Phase II Trial of Intraoperative Electron Beam Radiotherapy Boost at the Time of Breast Conserving Surgery With Oncoplastic Reconstruction in Women With Early-Stage Breast Cancer

Study identification

NCT ID
NCT02927912
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ohio State University Comprehensive Cancer Center
Other
Enrollment
108 participants

Conditions and interventions

Interventions

  • Electron Beam Therapy Radiation
  • Lumpectomy Procedure
  • Quality-of-Life Assessment Other
  • Questionnaire Administration Other
  • Radiation Therapy Radiation
  • Reconstructive Surgery Procedure

Radiation · Procedure · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 15, 2017
Primary completion
May 7, 2025
Completion
Nov 29, 2026
Last update posted
Feb 16, 2026

2017 – 2026

United States locations

U.S. sites
4
U.S. states
3
U.S. cities
4
Facility City State ZIP Site status
University of North Carolina Chapel Hill North Carolina 27599
University Hospitals Cleveland Ohio 44106
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210
Avera Cancer Institute Sioux Falls South Dakota 57105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02927912, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 16, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02927912 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →